Skip to main content
Clinical Trials/EUCTR2006-000838-12-AT
EUCTR2006-000838-12-AT
Active, not recruiting
Phase 1

Die Bedeutung des sensorischen Nervensystems für die Repigmentierung der Haut bei Vitiligo(engl.: The role of the sensory nervous system for repigmentation in vitiligo)

Peter Wolf MD, Department of Dermatology, Medical University of Graz0 sites15 target enrollmentJune 29, 2006

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Peter Wolf MD, Department of Dermatology, Medical University of Graz
Enrollment
15
Status
Active, not recruiting
Last Updated
9 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 29, 2006
End Date
TBD
Last Updated
9 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Peter Wolf MD, Department of Dermatology, Medical University of Graz

Eligibility Criteria

Inclusion Criteria

  • Patients with Vitiligo
  • Vitiligo for more than 6 months
  • Age \> 18 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • Present or past Malignant Melanoma or
  • Autoimmundiseases (Lupus erythemathosus, Dermatomyositis)
  • Immundeficiency
  • Systemic Treatment with corticosteroids and/or other immunosuppressive drugs
  • Pregnancy or Lactation
  • UV\-treatment of the vitiliginous skin areas under investigation within last 2 weeks
  • Significant Reduction in general health condition

Outcomes

Primary Outcomes

Not specified

Similar Trials